Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without Down syndrome

American Journal on Mental Retardation

Volumn 107, Issue 3, 2002, Pages

  Draheim, Christopher C ^a   McCubbin, Jeffrey A ^a   Williams, Daniel P ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOWN SYNDROME; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NEUROENDOCRINE DISEASE; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, LDL; DOWN SYNDROME; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MENTAL RETARDATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 18344366338     PISSN: 08958017     EISSN: None     Source Type: Journal    
DOI: 10.1352/0895-8017(2002)107<0201:DICDRB>2.0.CO;2     Document Type: Article

References (57)

1. Enzymatic determination of total serum cholesterol
2. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
3. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men?
4. Medical disorders of adults with mental retardation: A population study
5. Body fat distribution, insulin resistance, and metabolic diseases
6. The response to long-term overfeeding in identical twins
7. Does Down syndrome support homocysteine theory of arteriosclerosis?
8. Metabolic rate: A factor in developing obesity in children with Down syndrome?
9. Variability in B-mode ultrasound measurements in the atherosclerosis risk in communities (ARIC) study
10. Neurogenic atherosclerosis in mentally retarded persons
11. Visceral obesity, insulin resistance, and dyslipidemia: Contribution of endurance exercise training to the treatment of the plurimetabolic syndrome
12. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease
13. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years
14. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide
15. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge
16. Glucose: A continuous risk factor for cardiovascular disease
17. Prevention Conference V. Beyond Secondary Prevention: Identify the high-risk patient for primary prevention
18. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
19. Generalized equations for predicting density of women
20. Generation trends in sensory, physical, and behavioral abilities among older mentally retarded persons
21. Residential, health, and social service needs of elderly developmentally disabled persons
22. The 1988 report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure
23. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT
24. Prevalence of chronic medical conditions in adults with mental retardation: Comparison with the general population
25. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue
26. Endocrine-metabolic pattern and adipose tissue distribution
27. Plasma lipoprotein levels as predictors of cardiovascular death in women
28. Immunoassay of insulin; two antibody system. Plasma insulin in normal, subdiabetic, and diabetic rats
29. Hypothalamic-pituitary-adrenocortical function in adults with Down syndrome
30. Down's syndrome - An atheroma-free model
31. Anthropometric, reference data and prevalence of overweight
32. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
33. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report
34. Hyperlipidemia in patients with Down's syndrome
35. Human blood pressure determination by sphygmomanometry
36. Evaluation of the hexokinase/glucose-6-phosphate dehydrogenase method of determination of glucose in urine
37. Lipids and lipoproteins in persons with Down's syndrome
38. Syndrome X: 6 Years later
39. Diagnostic over-shadowing and professional experience with mentally retarded adults
40. Cardiovascular disease risk factors in adults with mental retardation
41. Health characteristics and behaviors of adults with mental retardation residing in three living arrangements
42. Accuracy of anthropometric equations for estimating body composition of mentally retarded adults
43. Atherosclerosis - An inflammatory disease
44. Insulin and risk of cardiovascular disease, a meta-analysis
45. Plasma lipids and lipoproteins in Down's syndrome
46. The sagittal waist diameter and mortality in men: The Baltimore Longitudinal Study on Aging
47. Insulin secretion in Down's syndrome
48. Comparative mortality of people with mental retardation in institutions and the community
49. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin
50. Function of the endothelium in arterial hypertension
51. Precision of recumbent anthropometry
52. Carbohydrate metabolism in Down's syndrome
53. Down's syndrome and atherosclerosis
54. Relation of body fat distribution in men and degree of coronary narrowing in coronary artery disease